ATYR
aTyr Pharma, Inc.
NASDAQ: ATYR · HEALTHCARE · BIOTECHNOLOGY
$0.81
+5.54% today
Updated 2026-04-30
Market cap
$76.98M
P/E ratio
—
P/S ratio
405.16x
EPS (TTM)
$-0.80
Dividend yield
—
52W range
$1 – $7
Volume
1.1M
aTyr Pharma, Inc. (ATYR) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
5 of 8
Last 8 quarters
Avg EPS surprise
-9.5%
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
+22.6%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-3.7%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
-7.8%
2026-03-12
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-12 | $-0.14 | +23.5% | $0.92 | $0.85 | -7.8% |
| 2025-11-06 | $-0.26 | -52.9% | $0.81 | $0.82 | +0.4% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.18 | $-0.14 | +23.5% | — | — |
| 2025-09-30 | $-0.17 | $-0.26 | -52.9% | $190000.00 | — |
| 2025-06-30 | $-0.18 | $-0.22 | -19.2% | — | — |
| 2025-03-31 | $-0.19 | $-0.17 | +10.5% | — | — |
| 2024-12-31 | $-0.23 | $-0.18 | +20.0% | — | — |
| 2024-09-30 | $-0.22 | $-0.23 | -3.5% | — | — |
| 2024-06-30 | $-0.24 | $-0.23 | +6.0% | — | — |
| 2024-03-31 | $-0.24 | $-0.23 | +4.2% | $235000.00 | — |
| 2023-12-31 | $-0.24 | $-0.25 | -4.2% | — | — |
| 2023-09-30 | $-0.20 | $-0.20 | +0.0% | $353000.00 | — |
| 2023-06-30 | $-0.28 | $-0.22 | +21.4% | — | — |
| 2023-03-31 | $-0.29 | $-0.29 | +0.0% | — | — |
Frequently asked questions
Has aTyr Pharma, Inc. beaten earnings estimates?
aTyr Pharma, Inc. has beaten Wall Street EPS estimates in 5 of its last 8 quarterly reports, with an average EPS surprise of -9.5% over the last 4 quarters.
How does ATYR stock react to earnings?
ATYR stock has moved an average of -3.7% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.